证券代码：002626 证券简称：金达威 20190821 投资者关系活动记录表 编号：20190821 | --- | --- | --- | |-----------------------------|-------------------------|--------------------------------------------------| | | | | | 投资者关系活动 | | 特定对象调研 □分析师会议 | | 类别 | □媒体采访 □业绩说明会 | | | | □ 新闻发布会 □路演活动 | | | | □现场参观 | | | | □ | 其他 （请文字说明其他活动内容） | | 参与单位名称及 | | 信达证券 研究开发中心研究员 王见鹿、毕翘楚 | | 人员姓名 | | | | 时间 | 2019 年 8 月 21 | 日下午 | | | | | | 地点 | 公司会议室 | | | 上市公司接待人 | 洪彦、林艺圃 | | | 员姓名 | | | | 投资者关系活动 主要内容介绍 | 调研方式：座谈 | | | | 主要内容： | | | | | 1、公司上半年经营情况介绍 ...

Group 1: Impact of US-China Trade Dispute - The company exports Coenzyme Q10 products to the US, with over 95% of the raw materials sourced from China [2] - The company is closely monitoring the progress of the US-China trade dispute and is taking proactive measures to minimize potential impacts [2] Group 2: Vitamin Price Trends - Recent statistics indicate that the supply of BASF lemon aldehyde is expected to normalize in the third quarter after equipment repairs [2] - Environmental regulations and production limits may lead to supply tightness, prompting the company to closely monitor price trends [2]

Group 1: Company Performance and Strategy - The company aims for better performance in 2018, building on a relatively positive 2017 [1] - The health supplement market in China is still in the education phase, indicating significant future growth potential [2] - The company plans to enhance its brand presence and marketing efforts to capture opportunities in the health industry, projected to reach 8 trillion yuan by 2020 [2] Group 2: Product Development and Market Trends - The company has seen high sales growth in coenzyme Q10, with expectations for continued price improvement [3] - The health supplement business is identified as a key profit growth area for the year, focusing on coenzyme Q10 and sports nutrition products [3] - The company is not currently involved in cosmetics, despite inquiries about potential collaborations [3] Group 3: Financial and Operational Insights - The company reported a 5.6% increase in R&D expenses compared to the previous year, aimed at enhancing core competitiveness through innovation [6] - There are no immediate impacts from rising coal prices or U.S.-China trade tensions on the company's operations [4] - The company has a robust cash flow and is considering further expansion in coenzyme and vitamin production [5] Group 4: Investor Relations and Communication - The company encourages investor engagement and is open to discussions, although site visits are currently not available [6] - The management expresses gratitude for investor confidence and commits to enhancing overall competitiveness to reward shareholders [4]

Group 1: Company Development Plans - The company aims to seize opportunities in the booming health industry in China, which is expected to show significant potential and vitality [2] - The focus will be on building a strong brand and expanding influence in the health industry while enhancing overall competitiveness [2] - The company plans to broaden sales channels and leverage rapid advancements in science and technology, along with "Internet +" strategies for multi-brand operations in the consumer sector [2] Group 2: Transformation and Future Focus - After acquiring a stake in iHerb Holdings, Inc., the company intends to capitalize on the global e-commerce penetration point and rapid growth in cross-border transactions [3] - A joint venture with iHerb will be established to promote the iHerb brand in Greater China, facilitating market expansion and new opportunities [3] - The company will enhance market proximity, understand industry trends, and accurately market products to boost overseas brand sales and influence in China [3] Group 3: Resource Sharing and Synergy - The overseas business system will share various resources to create complementary and synergistic relationships, leading to new profit growth points [3]

证券代码：002626 证券简称：金达威 厦门金达威集团股份有限公司投资者关系活动记录表 编号：20180828 | --- | --- | --- | --- | |-------------------------|---------------------------|----------------------------------|-------| | | | | | | 投资者关系活动 | 特定对象调研 □分析师会议 | | | | 类别 | □媒体采访 □业绩说明会 | | | | | □新闻发布会 | □路演活动 | | | | □现场参观 | | | | | □其他 | （请文字说明其他活动内容） | | | 参与单位名称及 人员姓名 | 东吴证券股份有限公司 | | | | 时间 2018 | 年 8 月 28 日下午 | | | | | | | | | 地点 公司会议室 | | | | | 上市公司接待人 员姓名 | 洪彦、洪航、常芃 | | | | | 调研方式：座谈 | | | | 投资者关系活动 | 主要内容： | | | | 主要内容介绍 | 1 、公司 2018 | 年半年度 ...

证券代码：002626 证券简称：金达威 编号：20201111 20201111 投资者关系活动记录表 | --- | --- | --- | |----------------|------------------------------|----------------------------------------------------| | | | | | 投资者关系活动 | √ | 特定对象调研 □分析师会议 | | 类别 | □ | 媒体采访 □业绩说明会 | | | □ 新闻发布会 □路演活动 | | | | □ 现场参观 | | | | □ | 其他 （请文字说明其他活动内容） | | 参与单位名称及 | | 东兴证券 食品饮料行业研究员王洁婷 | | 人员姓名 | | | | 时间 | 2020 年 11 月 11 | 日下午 | | 地点 | 公司会议室 | | | 上市公司接待人 | 副总经理兼董事会秘书洪彦女士 | | | 员姓名 | | 董事会办公室证券专员尤雅、冯清清 | | 投资者关系活动 | 1. 主要就公司 | 2020 年第三季度报告、生产经营情况、未来 | | 主要内 ...

证券代码：002626 证券简称：金达威 20221130 投资者关系活动记录表 编号：20221130 | --- | --- | --- | --- | --- | |-------------------------|------------------------------------------|-----------------|----------------------------------------------------|------------------------| | 投资者关系活动 | √特定对象调研 □分析师会议 | | | | | 类别 | □媒体采访 | □业绩说明会 | | | | | □新闻发布会 □路演活动 | | | | | | □现场参观 | | | | | | □其他 | | （请文字说明其他活动内容） | | | 参与单位名称及 人员姓名 | 国信证券 | | 陈青青、林俐辰、林瑾怡、甘艺红、施伟特 | | | 时间 | 2022 年 11 月 30 日上午 | | | | | 地点 | 公司会议室 | | | | | 上市公司接待人 员姓名 | 副总经 ...

证券代码：002626 证券简称：金达威 20210331 投资者关系活动记录表 编号：20210331 | --- | --- | --- | --- | |-----------------|------------------------------|------------------------------------------------------|----------------------------| | | | | | | 投资者关系活动 | | √特定对象调研 □分析师会议 | | | 类别 | □媒体采访 | □业绩说明会 | | | | | □新闻发布会 □路演活动 | | | | □现场参观 | | | | | □其他 | （请文字说明其他活动内容） | | | 参与单位名称及 | 山高国际资产管理有限公司 | 副总经理 王浩 | | | 人员姓名 | 山高深圳投资有限公司 | 谢宾 | | | 时间 2021 | 年 03 月 | 日下午 | | | 地点 公司会议室 | | | | | 上市公司接待人 | 副总经理兼董事会秘书洪彦女士 | | | | 员姓名 | | 董事会 ...

证券代码：002626 证券简称：金达威 20210629 投资者关系活动记录表 编号：20210629 | --- | --- | --- | |----------------|-----------------------------------|----------------------------------------------------------| | | | | | | √特定对象调研 | □分析师会议 | | | □媒体采访 | □业绩说明会 | | 投资者关系活动 | □新闻发布会 | □路演活动 | | 类别 | □现场参观 | | | | □其他 | | | 参与单位名称及 | | 久战久胜（广州）私募基金管理有限公司：李斌、邓泗文 | | 人员姓名 | 其他个人投资者 6 名 | | | 时间 | 2021 年 06 月 29 日上午 | | | 地点 | 公司会议室 | | | 上市公司接待人 | 财务总监：洪航 | | | 员姓名 | 董事会办公室工作人员：王庆祝 | | | | 证券事务专员：冯清清 | | | | 1. | 财务总监洪航先生介绍公司基本情况、公司 20 ...

Group 1: Company Overview - The company, Jindawei, is a leading enterprise in the A-share nutrition and health industry, with a strong competitive advantage and brand recognition built over many years of experience [2]. - The company maintains stable high gross margins for its raw material products due to established long-term relationships with major clients and suppliers [3]. Group 2: Market Position and Competitive Advantage - The health food and pharmaceutical raw materials industry has certain entry barriers, with relatively few major players, enhancing the company's bargaining power for high-purity, high-quality core raw materials [3]. - The company has a complete industrial chain layout from raw material supply to health product manufacturing and sales, providing a synergistic competitive advantage [3]. Group 3: NMN Product Development - Since launching NMN-related health products in 2020, the company has seen steady increases in consumer satisfaction and repurchase rates, indicating a positive outlook for NMN health products [3]. - The company is expanding its partnerships with major e-commerce platforms and plans to increase promotional efforts for NMN products through various channels [3].